日期: 2020 年 11 月 2 日

Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate

Stephen Saad Aspen Group Chief Executive

Durban, South Africa – Aspen is pleased to announce tha… 继续阅读Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate

我们的使命

更多详情

致力于提高患者的生命健康和质量

我们的愿景

更多详情

作为一个负责任的企业公民，在全球提供优质和患者可及的药物，传递我们的价值。

我们的价值观

更多详情

我们的价值观是爱施健存立和发展的基石。集团上下以此为指引，为实现集团目标而共同奋斗。

aspen-holdings-logo-white-img

关于我们

企业责任

职业发展

媒体中心

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.